Shipments of Vietnamese Shrimp contaminated with antibiotics discovered by FDA again in November


December 14, 2015 Facebook Twitter LinkedIn Google+ Aquaculture News,News-NorthAmerica



The U.S. Food and Drug Administration (FDA) published information regarding entry line refusals for the month of November. The agency reported refusing a total of 129 seafood entry lines last month.  Of these, 9 (7.0%) were of shrimp entry lines refused for reasons related to banned antibiotics.

With one month left in 2015, the FDA has now refused a record total of 386 entry lines of shrimp products for reasons related to banned antibiotics.

The nine entry line refusals in November principally involved shrimp manufactured by one Vietnamese company.  The refusals were reported from four different FDA District Offices spread across the country:

  • Bac Lieu Fisheries (Vietnam), a company listed on Import Alert 16-124 for sulfadoxine on June 19, 2015 but not currently listed on Import Alert 16-129, had five entry lines refused for shrimp contaminated with veterinary drug residues in the Los Angeles District, two entry lines refused for shrimp contaminated with veterinary drug residues in that Atlanta District, and one entry line refused for shrimp contaminated with veterinary drug residues in the New York District; and
  • Globe Season Enterprises (Malaysia), a company not currently listed on either Import Alert 16-124 or Import Alert 16-129, had one entry line refused for shrimp contaminated with veterinary drug residues in the Baltimore District.

The eight entry line refusals of shrimp shipped from Vietnam, by three different FDA District Offices, are the first refusals of Vietnamese shrimp for reasons related to banned antibiotics since May 2015.  In total, the FDA has reported refusing 38 entry lines of Vietnamese shrimp for banned antibiotics this year, the second most since 2002 (48 entry lines of Vietnamese shrimp were refused for banned antibiotics in 2014).

Full article at Southern Shrimp Alliance